vimarsana.com
Home
Live Updates
Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients : comparemela.com
Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients
/PRNewswire/ -- CSL Vifor is pleased that its partner Akebia Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved...
Related Keywords
Melbourne ,
Victoria ,
Australia ,
Japan ,
Switzerland ,
United States ,
Thomas Hutter ,
Glennm Chertow ,
Clin Nephrol ,
Steering Committee ,
Drug Administration ,
Fresenius Medical Care ,
Vifor International ,
Akebia Therapeutics Inc ,
National Institute Of Diabetes ,
Clin Lab Haematol ,
National Institutes Of Health ,
Division Of Nephrology At Stanford University ,
Akebia Therapeutics ,
General Manager ,
Stanford University ,
Executive Steering Committee ,
New England Journal ,
Important Safety Information ,
Fresenius Kidney Care ,
Vifor Fresenius Medical Care Renal Pharma ,
Safety Information ,
Myocardial Infarction ,
Venous Thromboembolism ,
Adverse Reactions ,
Anemia Due ,
Chronic Kidney Disease ,
Full Prescribing Information ,
Anaemia Management ,
Partial Update ,
States Renal Data ,
Data Report ,
National Institutes ,
National Institute ,
Kidney Diseases ,
comparemela.com © 2020. All Rights Reserved.